Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hepatitis B, Chronic × Methods × Clear all

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 41 Neoplasms 34 Lung Neoplasms 22 Colorectal Neoplasms 22 Prostatic Neoplasms 15 Motor Activity 12 Uterine Cervical Neoplasms 11 Colonic Neoplasms 10 Pancreatic Neoplasms 9 Carcinoma, Non-Small-Cell Lung 9 Rectal Neoplasms 8 Melanoma 8 Anxiety Disorders 8 Urinary Bladder Neoplasms 7 Obesity 7 Lymphoma 7 Hematologic Neoplasms 7 Head and Neck Neoplasms 6 Depression 6 Breast Carcinoma In Situ 6 Vulvar Neoplasms 5 Pain 5 Ovarian Neoplasms 5 Neoplasm Metastasis 5 Endometrial Neoplasms 5 Stomach Neoplasms 4 Sarcoma 4 Papillomavirus Infections 4 Fatigue 4 Vaginal Neoplasms 3

Interventions

Tenofovir 5 entecavir 2 peginterferon alfa-2b 1 peginterferon alfa-2a 1 ibrutinib 1 Radiofrequency Ablation 1 Observation 1 Nucleosides 1 Methods 1 Interferons 1 Cholecalciferol 1 Acids 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07120750 2025-08-13

PRTRAS 001

Shenzhen Third People's Hospital

Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Hepatitis B, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡